Celularity Inc. (NASDAQ: CELU) Stock Information | RedChip

Celularity Inc. (NASDAQ: CELU)


$2.3600
+0.0300 ( +4.43% ) 0.0K

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Market Data


Open


$2.3600

Previous close


$2.3300

Volume


0.0K

Market cap


$52.39M

Day range


$2.2600 - $2.2600

52 week range


$1.3000 - $7.9700

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Dec 20, 2024
4 Insider transactions 1 Dec 19, 2024
3 Insider transactions 1 Dec 19, 2024
10-q Quarterly Reports 95 Dec 06, 2024
8-k 8K-related 19 Dec 02, 2024
8-k 8K-related 14 Nov 29, 2024
def Proxies and info statements 4 Nov 19, 2024
nt Quarterly Reports 1 Nov 15, 2024
8-k 8K-related 14 Nov 08, 2024
8-k 8K-related 15 Nov 07, 2024

Latest News